NPCE - Neuropace - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NPCE is currently covered by 5 analysts with an average price target of $18.8. This is a potential upside of $4.64 (29.92%) from yesterday's end of day stock price of $14.47.

Neuropace's activity chart (see below) currently has 80 price targets and 75 ratings on display. The stock rating distribution of NPCE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 71.86% with an average time for these price targets to be met of 162.2 days.

Highest price target for NPCE is $22, Lowest price target is $16, average price target is $18.8.

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 29-Jul-2026. First documented stock forecast 17-May-2021.

Best performing analysts who are covering NPCE - Neuropace:

Ross Osborn Priya Sachdeva Vik Chopra Frank Takkinen Yi Chen

Currently out of the existing stock ratings of NPCE, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-May-2025

$20

$5.23 (35.41%)

$20

Buy Since 21-Jan-2025

$22

$5.53 (33.58%)

$18

Buy Since 08-Nov-2023

$20

$3.53 (21.43%)

$16

Buy Since 29-May-2024

$16

$-0.47 (-2.85%)

$15

Show more analysts

Please expand the browser size to see the chart

What is NPCE (Neuropace) average time for price targets to be met?

On average it took 162.2 days on average for the stock forecasts to be realized with a an average price target met ratio 71.86

Which analyst has the current highest performing score on NPCE (Neuropace) with a proven track record?

ROSS OSBORN

Which analyst has the most public recommendations on NPCE (Neuropace)?

Ross Osborn works at CANTOR FITZGERALD and has 2 price targets and 2 ratings on NPCE

Which analyst is the currently most bullish on NPCE (Neuropace)?

Priya Sachdeva with highest potential upside - $7.23

Which analyst is the currently most reserved on NPCE (Neuropace)?

Drew Ranieri with lowest potential downside - -$8.47

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?